BSE Live
Nov 10, 16:01Prev. Close
260.55
Open Price
260.80
Bid Price (Qty.)
260.00 (1)
Offer Price (Qty.)
272.00 (315)
NSE Live
Nov 10, 15:58Prev. Close
260.95
Open Price
261.60
Bid Price (Qty.)
265.55 (100)
Offer Price (Qty.)
0.00 (0)
| Key Financial Ratios of Indoco Remedies (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | -0.95 | 12.66 | 15.34 | 16.77 | 10.03 | |
| Diluted EPS (Rs.) | -0.95 | 12.64 | 15.32 | 16.77 | 10.03 | |
| Cash EPS (Rs.) | 9.70 | 22.20 | 23.00 | 25.34 | 17.96 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 119.61 | 122.22 | 111.45 | 98.13 | 83.44 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 119.61 | 122.22 | 111.45 | 98.13 | 83.44 | |
| Dividend / Share(Rs.) | 0.20 | 1.50 | 2.25 | 2.25 | 1.50 | |
| Revenue from Operations/Share (Rs.) | 164.58 | 194.27 | 180.87 | 167.09 | 134.60 | |
| PBDIT/Share (Rs.) | 15.88 | 28.91 | 31.17 | 35.74 | 24.60 | |
| PBIT/Share (Rs.) | 5.23 | 19.36 | 23.51 | 27.17 | 16.66 | |
| PBT/Share (Rs.) | -0.80 | 16.62 | 20.79 | 25.64 | 14.25 | |
| Net Profit/Share (Rs.) | -0.95 | 12.65 | 15.34 | 16.77 | 10.03 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 9.65 | 14.88 | 17.23 | 21.38 | 18.27 | |
| PBIT Margin (%) | 3.17 | 9.96 | 12.99 | 16.26 | 12.38 | |
| PBT Margin (%) | -0.48 | 8.55 | 11.49 | 15.34 | 10.59 | |
| Net Profit Margin (%) | -0.57 | 6.51 | 8.48 | 10.03 | 7.44 | |
| Return on Networth / Equity (%) | -0.79 | 10.35 | 13.76 | 17.08 | 12.01 | |
| Return on Capital Employed (%) | 3.20 | 12.76 | 17.57 | 23.60 | 16.91 | |
| Return on Assets (%) | -0.39 | 5.94 | 8.51 | 10.38 | 7.01 | |
| Total Debt/Equity (X) | 0.67 | 0.44 | 0.31 | 0.27 | 0.28 | |
| Asset Turnover Ratio (%) | 0.73 | 0.99 | 1.06 | 1.10 | 94.20 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 1.37 | 1.60 | 1.89 | 1.81 | 1.52 | |
| Quick Ratio (X) | 0.85 | 1.05 | 1.13 | 1.08 | 0.94 | |
| Inventory Turnover Ratio (X) | 4.51 | 1.40 | 1.29 | 1.44 | 5.22 | |
| Dividend Payout Ratio (NP) (%) | -158.29 | 17.77 | 14.66 | 8.94 | 2.99 | |
| Dividend Payout Ratio (CP) (%) | 15.44 | 10.13 | 9.78 | 5.92 | 1.67 | |
| Earnings Retention Ratio (%) | 258.29 | 82.23 | 85.34 | 91.06 | 97.01 | |
| Cash Earnings Retention Ratio (%) | 84.56 | 89.87 | 90.22 | 94.08 | 98.33 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 2,878.10 | 3,508.10 | 3,302.06 | 3,694.92 | 2,857.75 | |
| EV/Net Operating Revenue (X) | 1.90 | 1.96 | 1.98 | 2.40 | 2.30 | |
| EV/EBITDA (X) | 19.64 | 13.16 | 11.50 | 11.22 | 12.61 | |
| MarketCap/Net Operating Revenue (X) | 1.42 | 1.69 | 1.80 | 2.25 | 2.14 | |
| Retention Ratios (%) | 258.29 | 82.22 | 85.33 | 91.05 | 97.00 | |
| Price/BV (X) | 1.95 | 2.69 | 2.92 | 3.84 | 3.46 | |
| Price/Net Operating Revenue | 1.42 | 1.69 | 1.80 | 2.25 | 2.14 | |
| Earnings Yield | 0.00 | 0.04 | 0.05 | 0.04 | 0.03 |
07.11.2025
Indoco Remedies Consolidated September 2025 Net Sales at Rs 484.67 crore, up 12.02% Y-o-Y
25.07.2025
24.07.2025
Indoco Remedies Consolidated June 2025 Net Sales at Rs 437.89 crore, up 1.48% Y-o-Y
24.07.2025
Indoco Remedies Standalone June 2025 Net Sales at Rs 392.53 crore, down 2.22% Y-o-Y
07.11.2025
Indoco Remedies Consolidated September 2025 Net Sales at Rs 484.67 crore, up 12.02% Y-o-Y
24.07.2025
Indoco Remedies Consolidated June 2025 Net Sales at Rs 437.89 crore, up 1.48% Y-o-Y
24.07.2025
Indoco Remedies Standalone June 2025 Net Sales at Rs 392.53 crore, down 2.22% Y-o-Y
27.05.2025
Indoco Remedies Consolidated March 2025 Net Sales at Rs 390.21 crore, down 13.22% Y-o-Y
12.07.2023
Indoco Remedies Q1 PAT may dip 0.1% YoY to Rs 38.5 cr: Nirmal Bang
17.01.2023
Indoco Remedies Q3 PAT seen up 46.1% YoY to Rs 482 cr: Nirmal Bang
08.07.2022
Indoco Remedies Q1 PAT seen up 4.4% YoY to Rs 41.4 cr: Prabhudas Lilladher
14.04.2022
Indoco Remedies Q4 PAT seen up 52.9% YoY to Rs 38.2 cr: Prabhudas Lilladher